Search Results - Rachel A Woolaver

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    HDAC inhibitors overcome immunotherapy resistance in B-cell lymphoma by Xiaoguang Wang, Brittany C. Waschke, Rachel A Woolaver, Samantha M. Y. Chen, Zhangguo Chen, Jing H. Wang

    Published in Protein & Cell (2020-03-01)
    Get full text
    Article


  2. 2

    Differences in TCR repertoire and T cell activation underlie the divergent outcomes of antitumor immune responses in tumor-eradicating versus tumor-progressing hosts by Antonio Jimeno, Rachel A Woolaver, Xiaoguang Wang, Alexandra L Krinsky, Brittany C Waschke, Samantha M Y Chen, Vince Popolizio, Andrew G Nicklawsky, Dexiang Gao, Zhangguo Chen, Xiao-Jing Wang, Jing Hong Wang

    Published in Journal for ImmunoTherapy of Cancer (2021-01-01)
    Get full text
    Article


  3. 3

    Differential responses to immune checkpoint inhibitor dictated by pre-existing differential immune profiles in squamous cell carcinomas caused by same initial oncogenic drivers by Samantha M. Y. Chen, Vince Popolizio, Rachel A. Woolaver, Huaibin Ge, Alexandra L. Krinsky, Jessy John, Etienne Danis, Yao Ke, Yonatan Kramer, Li Bian, Andrew G. Nicklawsky, Dexiang Gao, Silvia Liu, Zhangguo Chen, Xiao-jing Wang, Jing H. Wang

    Get full text
    Article


Search Tools: